Sign up for Table of Contents Alerts.

Email this page

Print this page

Commentary

ErbB4 targeting approaches forpProstate cancer treatment

DL Wheeler, VM Rangnekar and SR Schwarze

Purchase article for $19

Subscribe to this journal for $129/year

Commentary to:

Anti-ErbB4 targeted therapy combined with radiation therapy in prostate cancer: Results of in-vitro and in-vivo studies

AKIVA VEXLER, GHALIB LIDAWI, VERED LOEW, ITAY BARNEA, VICTORIYA KARAUSH, ALEXANDER SHTABSKY, RAMI BEN-YOSEF

Authors

DL Wheeler

Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI

VM Rangnekar

Departments of Radiation Oncology and Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY

SR Schwarze

Molecular and Cellular Biochemistry and Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY

Purchase article for $19

Subscribe to this journal for $129/year